Livercellgram
Phase 2Biologic
Livercellgram is one of 5 biologic programs targeting Alcoholic Liver Cirrhosis. It is currently in Phase 2.
1
Indications
1
Total Trials
0
Active Trials
4
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
4 competitors in Alcoholic Liver Cirrhosis
#DrugCompanyPhaseTrials
1Cipro
BayerApproved
Lioresal
NovartisApproved
Mesenchymal Stem Cell
RRohto Pharmaceutical Co., Ltd.
Phase 2
Livercellgram
PPharmicell Co., Ltd.
Phase 2
Cellgram-LC
PPharmicell Co., Ltd.
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Livercellgram. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Biologic[2]
- Highest Phase
- Phase 2[1]
- Company
- PPharmicell Co., Ltd.